+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Relationship between the amount of copper and zinc given to critically ill patients on total parenteral nutrition and plasma and erythrocyte copper and zinc levels

Relationship between the amount of copper and zinc given to critically ill patients on total parenteral nutrition and plasma and erythrocyte copper and zinc levels

Nutricion Hospitalaria 23(4): 373-382

Complications resulting from zinc and copper deficiency, or adverse effects from excessive zinc and copper intake should be avoided during total parenteral nutrition (TPN). This study was conducted on critically ill patients requiring TPN to determine the relationship between the zinc and copper levels of the TPN mixtures, patients' clinical progression, and changes in plasma levels of zinc, serum levels of copper, and erythrocyte levels of zinc and copper. 29 adult critically ill patients following pancreatitis or after a major abdominal surgery were studied. Zinc and copper levels in TPN, plasmatic zinc levels, copper serum levels and erythrocyte levels of zinc and copper were determined at the onset and at the end of the treatment (5-21 days) (using Atomic Absorption Spectrometry). The mean+/-standard deviation (and ranges in parenthesis) of zinc and copper levels in TPN were (microg/mL): zinc: 4.2+/-1.7 (1.8 a 9.3); copper: 0.94+/-0.66 (0.1 a 3.1). Biochemical parameters at the onset and at the end of the treatment were, respectively: (microg/mL): plasmatic zinc: 80+/-45 (29-205) and 122+/-56 (37-229); erythrocyte zinc: 2,300+/-1,070 (790-5,280) and 2,160+/-920 (790-4,440); serum copper (microg/dL): 124+/-35 (62-211) and 128+/-41 (60- 238); erythrocyte copper (microg/dl): 72+/-39 (4-183) and 70+/-41 (9-156). Plasmatic and erythrocyte zinc levels did not correlated neither at the onset nor at the end of the treatment. Changes in erythrocyte zinc levels correlated with daily administered zinc (mg/d) in the parenteral nutrition (r=0.38). Serum copper and erythrocyte copper showed significant correlation at the onset (p=0.0005) and at the end of treatment (p=0.008). Changes of serum or erythrocyte copper levels showed a significant correlation with daily administered copper (r=0.31 and 0.26, respectively). These results show that: 1) determination of erythrocyte zinc and copper levels in these critically ill patients would help to control zinc and copper administration levels in TPN and avoid adverse effects; 2) TPN Zn levels should be less than 8.1 mg/d, and 3) TPN Cu levels higher than 1.2 mg/d would not be recommended.

(PDF 0-2 workdays service: $29.90)

Accession: 055468972

Download citation: RISBibTeXText

PMID: 18604324

Related references

Plasmatic and erythrocytic zinc and copper levels in critically ill patients on parenteral nutrition and their relationship with formulas content: preliminary study. Nutricion Hospitalaria 20(3): 189-196, 2005

Relationship among levels of leptin and zinc, copper, and zinc/copper ratio in plasma of patients with essential hypertension and healthy normotensive subjects. Biological Trace Element Research 100(2): 117-123, 2004

A prospective study of serum copper and zinc levels in patients receiving total parenteral nutrition. American Journal of Clinical Nutrition 29(1): 70-77, 1976

Serum zinc, copper, and selenium concentrations in preterm infants receiving enteral nutrition or parenteral nutrition supplemented with zinc and copper. Journal of pediatrics 104(5): 763-768, 1984

Plasma copper and zinc levels in patients with malignant tumors of digestive organs clinical evaluation of the copper zinc ratio. Cancer 42(2): 626-631, 1978

Zinc and copper balances in cancer patients on total parenteral nutrition. Proceedings of the American Association for Cancer Research & American Society of Clinical Oncology 22: 174, 1981

Maintenance of serum levels of the trace elements copper zinc iron magnesium cobalt fluorine selenium and molybdenum in cancer patients under total parenteral nutrition. Gastroenterologie Clinique et Biologique 10(3): 259, 1986

Trace metal requirements in total parenteral nutrition 5. formation constants for the copper ii histidine ternary complexes with threonine lysine glycine phenyl alanine valine and cystine and discussion of their implications regarding the copper distribution in blood plasma during total parenteral nutrition and the evaluation of the daily dose of copper. Journal of Inorganic Biochemistry 20(2): 113-130, 1984

Zinc and copper abnormalities in fasting patients undergoing total parenteral nutrition. Archivos de Investigacion Medica 12(2): 241-251, 1981

Sequential estimation of zinc and copper in whole blood and urine of patients during total parenteral nutrition. Bollettino della Societa Italiana de Biologia Sperimentale 55(18, II): 179, 1979

Effect of total parenteral nutrition on the zinc, copper, and manganese status of patients with catabolic disease. Scandinavian Journal of Gastroenterology 21(4): 421-427, 1986

Comparison of copper and zinc levels in plasma and erythrocyte of HD and CAPD patients. Nephrology Dialysis Transplantation 14(9): A122, Sept, 1999

Effects of varying dietary copper and zinc levels and subsequent copper supplementation on plasma and erythrocyte superoxide dismutase in weanling rats. FASEB Journal 9(4): A738, 1995

Abnormalities of zinc and copper during total parenteral nutrition. Annals of Surgery 189(1): 120-128, 1979

Zinc and copper replacement during total parenteral nutrition. American Journal of Clinical Nutrition 34(9): 1853-1860, 1981